• Activity in prelimbic cortex subserves fear memory reconsolidation over time. Stern CA, Gazarini L, Vanvossen AC, Hames MS, Bertoglio LJ. Learning and Memory 2014, 21(1):14-20. PDF

• Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting α1- and β-adrenergic receptors. Gazarini L, Stern CA, Carobrez AP, Bertoglio LJ. Learning and Memory 2013, 19;20(4):210-219. PDF

• On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Stern CA, Gazarini L, Takahashi RN, Guimarães FS, Bertoglio LJ. Neuropsychopharmacology 2012, 37: 2132-2142. PDF

• Protein synthesis in dorsal hippocampus supports the drug tolerance induced by prior elevated plus-maze experience. Gazarini L, Stern CA, Bertoglio LJ. Neuroscience. 2011. PDF

• Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest. Stern CA, Monte FH, Gazarini L, Carobrez AP, Bertoglio LJ. Neuroscience. 2010, 170: 214-222. PDF

• Pentylenetetrazole as an unconditioned stimulus for olfactory and contextual fear conditioning in rats. Cavalli J, Bertoglio LJ, Carobrez AP. Neurobiol. Learn. Mem. 2009, 92:512-518. PDF

• Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze. Moraes CL, Bertoglio LJ, Carobrez AP. Behav. Brain Res. 2008, 194:181-186. PDF

• Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus. Santos CJ, Stern CA, Bertoglio LJ. Behav Pharmacol. 2008, 19:357-360. PDF

• Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze. Stern CA, Carobrez AP, Bertoglio LJ. Pharmacol. Biochem. Behav. 2008, 90:545-550. PDF

• Cholecystokinin-2 receptors modulate freezing and escape behaviors evoked by the electrical stimulation of the rat dorsolateral periaqueductal gray. Bertoglio LJ, de Bortoli VC, Zangrossi H Jr. Brain Res. 2007, 1156:133-138. PDF

• Involvement of dorsolateral periaqueductal gray N-methyl-D-aspartic acid glutamate receptors in the regulation of risk assessment and inhibitory avoidance behaviors in the rat elevated T-maze. Bertoglio LJ, Zangrossi H Jr. Behav. Pharmacol. 2006, 17:589-596. Erratum in: Behav. Pharmacol. 2006, 17:737. PDF ERRATA

• Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Bertoglio LJ, Joca SR, Guimarães FS. Behav. Brain Res. 2006, 175:183-188. PDF

• Lack of interaction between NMDA and cholecystokinin-2 receptor-mediated neurotransmission in the dorsolateral periaqueductal gray in the regulation of rat defensive behaviors. Bertoglio LJ, Guimarães FS, Zangrossi H Jr. Life Sci. 2006, 79:2238-2244. PDF

• Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats. Bertoglio LJ, Zangrossi H Jr. Brain Res. 2005, 1059:46-51. PDF

• Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Carobrez AP, Bertoglio LJ. Neurosci. Biobehav Rev. 2005, 29:1193-1205. PDF

• Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats. Bertoglio LJ, Anzini C, Lino-de-Oliveira C, Carobrez AP. Behav. Brain Res. 2005, 162:99-107. PDF

• Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Bertoglio LJ, Carobrez AP. Behav. Pharmacol. 2004, 15:45-54. PDF

• Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Bertoglio LJ, Carobrez AP. Psychopharmacology 2003, 170:335-342. PDF

• Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Bertoglio LJ, Carobrez AP. Pharmacol. Biochem. Behav. 2002, 73:963-969. PDF

• Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions. Bertoglio LJ, Carobrez AP. Behav. Brain Res. 2002, 132:135-143. PDF

• Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Bertoglio LJ, Carobrez AP. Pharmacol. Biochem. Behav. 2002, 72:449-455. PDF

• Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Bertoglio LJ, Carobrez AP. Behav. Brain Res. 2000, 108:197-203. PDF

Voltar